RT Journal Article
SR Electronic
T1 Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP 285
OP 293
DO 10.1136/ard.2005.038638
VO 65
IS 3
A1 Da Silva, J A P
A1 Jacobs, J W G
A1 Kirwan, J R
A1 Boers, M
A1 Saag, K G
A1 Inês, L B S
A1 de Koning, E J P
A1 Buttgereit, F
A1 Cutolo, M
A1 Capell, H
A1 Rau, R
A1 Bijlsma, J W J
YR 2006
UL http://ard.bmj.com/content/65/3/285.abstract
AB Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.